<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02917486</url>
  </required_header>
  <id_info>
    <org_study_id>35RC15_8901</org_study_id>
    <nct_id>NCT02917486</nct_id>
  </id_info>
  <brief_title>EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION</brief_title>
  <acronym>EC-MOTION</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <brief_summary>
    <textblock>
      The objective of the study is to investigate the exposure difference between antibiotic
      studied patients in intensive care with Extracorporeal Membrane Oxygenation and patients
      without Extracorporeal Membrane Oxygenation.

      The exhibition is evaluated by population pharmacokinetic modeling.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measure exposure to piperacillin</measure>
    <time_frame>Day 1</time_frame>
    <description>evaluated by population pharmacokinetic modeling and is defined by the time during which the antibiotic concentration is greater than 4 times the critical concentration of the germ to treat</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>ECMO piperacillin</arm_group_label>
    <description>patients in intensive care treated with ECMO with antiinfective therapy : piperacillin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without ECMO piperacillin</arm_group_label>
    <description>patients in intensive care without ECMO with antiinfective therapy : piperacillin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>ECMO piperacillin</arm_group_label>
    <arm_group_label>without ECMO piperacillin</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in intensive care treated with ECMO or without ECMO
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years

          -  Hospitalisation in intensive care

          -  Treatment with ECMO or without ECMO

          -  Introducing sepsis treated with an anti-infective molecule studied (piperacillin) for
             less than 48 hours

          -  With an arterial catheter

          -  Patient Information or their next of kin according to the patients status.

        Exclusion Criteria:

          -  Pregnancy

          -  Major person under legal protection (backup justice, trusteeship, quardianship),
             person deprived of liberty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Fillatre</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Fillatre</last_name>
    <email>pierre.fillatre@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne Ganivet</last_name>
    <email>anne.ganivet@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Fillatre</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ExtraCorporeal Membrane Oxygenation</keyword>
  <keyword>patient in intensive care</keyword>
  <keyword>pharmacokinetic modeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Piperacillin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

